GSA Capital Partners’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$528K Sell
24,474
-54,819
-69% -$1.18M 0.04% 878
2025
Q1
$1.32M Buy
79,293
+5,766
+8% +$95.8K 0.12% 219
2024
Q4
$1.35M Buy
73,527
+6,431
+10% +$118K 0.1% 234
2024
Q3
$1.03M Sell
67,096
-113,604
-63% -$1.75M 0.08% 449
2024
Q2
$2.94M Buy
180,700
+69,306
+62% +$1.13M 0.21% 46
2024
Q1
$2.06M Buy
111,394
+97,987
+731% +$1.81M 0.16% 93
2023
Q4
$420K Sell
13,407
-66,442
-83% -$2.08M 0.04% 909
2023
Q3
$1.66M Buy
79,849
+57,119
+251% +$1.19M 0.14% 166
2023
Q2
$544K Buy
+22,730
New +$544K 0.05% 693
2022
Q3
Sell
-30,447
Closed -$429K 1465
2022
Q2
$429K Buy
+30,447
New +$429K 0.06% 592
2021
Q4
Sell
-68,330
Closed -$1.14M 1369
2021
Q3
$1.14M Buy
+68,330
New +$1.14M 0.12% 250
2020
Q1
Sell
-9,486
Closed -$406K 999
2019
Q4
$406K Sell
9,486
-1,152
-11% -$49.3K 0.05% 803
2019
Q3
$383K Buy
+10,638
New +$383K 0.05% 721
2018
Q4
Sell
-11,717
Closed -$243K 1299
2018
Q3
$243K Buy
+11,717
New +$243K 0.01% 1413
2016
Q1
Sell
-9,731
Closed -$347K 1627
2015
Q4
$347K Sell
9,731
-24,977
-72% -$891K 0.02% 1384
2015
Q3
$1.15M Sell
34,708
-7,369
-18% -$244K 0.06% 548
2015
Q2
$1.76M Sell
42,077
-27,218
-39% -$1.14M 0.07% 471
2015
Q1
$2.26M Buy
69,295
+58,062
+517% +$1.89M 0.09% 278
2014
Q4
$357K Buy
+11,233
New +$357K 0.02% 1160
2014
Q2
Sell
-24,751
Closed -$602K 1775
2014
Q1
$602K Buy
+24,751
New +$602K 0.04% 655